What are peptides?
Peptides are molecules composed of two or more amino acids joined by peptide bonds. Unlike proteins, which consist of long amino acid chains (more than 50), peptides are shorter - typically from 2 to 50 amino acids. It is precisely because of their small size that peptides can easily penetrate cell membranes and directly influence gene expression processes.
The human body naturally produces peptides - they regulate hormonal activity, the immune system, digestion, nervous system functions, and many other processes. However, with age, peptide production decreases, which contributes to the aging process and the development of chronic diseases.
Peptide research in a modern laboratory
Peptide bioregulators: a scientific perspective
The concept of peptide bioregulators was developed by Russian scientist Professor Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology. Over more than 40 years of scientific research, thousands of peptides and their effects on the body have been studied.
Prof. Khavinson discovered that each organ and tissue has specific peptides that regulate the functions of that organ. When these peptides are taken as dietary supplements, they act as "information messengers" - transmitting signals to specific cells and helping to restore normal organ function.
This discovery has been confirmed in numerous clinical studies involving more than 15 million people. Research results have been published in prestigious scientific journals and recognized by the international scientific community.
How do peptide bioregulators work?
The mechanism of action of peptide bioregulators is based on several key principles:
- Organ specificity - each peptide preparation targets specific organs or tissues. For example, Cerluten is designed to support the brain and nervous system, while Chelohart supports heart muscle function.
- Gene regulation - peptides interact with DNA and regulate protein synthesis, helping cells perform their functions optimally.
- Cell renewal - they stimulate natural cell regeneration processes, helping the body recover.
- Slowing aging - they restore peptide production that decreases with age, thus slowing the aging processes at the organ level.
Main groups of peptide bioregulators
Peptide bioregulators are divided into several main groups according to the organs they affect:
Nervous system and brain
Cerluten - brain and central nervous system peptides. Helps maintain memory, concentration, and cognitive function health. Pinealon - a synthetic peptide designed to support brain functions.
Heart and blood vessels
Chelohart - heart muscle peptides. Ventfort - blood vessel wall peptides. Vesugen - a synthetic vascular peptide.
Immune system
Kristagen - a synthetic immune system peptide. Vladonix - thymus peptides, important for immunity.
Musculoskeletal system
Sigumir - cartilage and bone tissue peptides. Bonomarlot - bone marrow peptides.
Peptide usage principles
Peptide bioregulators are typically taken in courses. It is recommended to:
- Take 1-2 capsules per day before meals
- Course duration - 30 days
- The course can be repeated every 3-6 months
- Several different peptides can be combined at the same time
- Peptides have no known side effects and do not interact with medications
Why choose peptide bioregulators?
Peptide bioregulators offer a unique approach to health - they not only relieve symptoms but help restore normal organ function at the cellular level. They are:
- Natural - derived from animal tissues or synthesized in a laboratory
- Safe - no side effects have been identified over 40+ years of research
- Scientifically proven - confirmed by clinical studies and patents
- Universal - suitable for people of any age for prevention and maintenance
If you want to learn more about specific peptide bioregulators and their application for your health, visit our product catalog or contact us for a consultation.
Sources
- Khavinson, V.Kh. "Peptides and Ageing." Neuroendocrinology Letters, Vol. 24, No. 3-4, 2003, pp. 144-149.
- Khavinson, V.Kh., Malinin, V.V. Gerontological Aspects of Genome Peptide Regulation. Karger, Basel, 2005.
- Khavinson, V. "Peptide regulation of aging: 35-year research experience." Bulletin of Experimental Biology and Medicine, Vol. 152, No. 1, 2011, pp. 7-12.
- Institute of Bioregulation and Gerontology, Saint Petersburg - scientific publications and clinical trial data.
- Khavinson, V.Kh., et al. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bulletin of Experimental Biology and Medicine, Vol. 135, No. 6, 2003, pp. 590-592.
